EU ingredient rules · 1 min read
Genistein in cosmetics: EU rules
Quick answer: Genistein is a restricted cosmetic ingredient in the EU: Annex III (entry 373) allows it only within set limits, at up to 0.007% in the ready-to-use product. CosIng lists its functions as skin conditioning (other).
Key facts
| INCI name | GENISTEIN |
|---|---|
| CAS number | 446-72-0 |
| EC number | 207-174-9 |
| EU status | Restricted (Annex III, entry 373) |
| Functions (CosIng) | Skin conditioning (other) |
What it does in a product
- Skin conditioning (other): Conditions the skin in ways not covered by the other skin-conditioning groups.
Annex III: restricted substances, entry 373
Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.
The entry is listed as Genisteol; 4',5,7-Trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
Maximum concentration in the ready-to-use product: 0.007%
Other conditions:
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.
Most recent legal act listed by CosIng for this entry: Regulation (EU) 2024/996.
Scientific Committee on Consumer Safety (SCCS) opinions:
Why it matters for shelf life
The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.
Not sure how to read a label? What an INCI name is · How ingredient lists work
Source
European Commission, CosIng (Cosmetic Ingredients database), entries for GENISTEIN and Annex III/373, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.